Diebold, Inc. (DBD) Misses Q2 EPS by 9c; Lowers FY12 non-GAAP EPS Outlook
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $83.06 +0.45%
EPS Growth %: +30.9%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +30.9%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q2 EPS of $0.49, $0.09 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $743.2 million versus the consensus estimate of $731.23 million.
Diebold, Inc. sees FY2012 EPS of $2.50-$2.60, versus prior guidance of $2.50-$2.70 and the consensus of $2.68.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Diebold, Inc. sees FY2012 EPS of $2.50-$2.60, versus prior guidance of $2.50-$2.70 and the consensus of $2.68.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
